CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Medfield Diagnostics AB is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Medfield Diagnostics AB
Medicinaregatan 8B
Phone: +46 31160668p:+46 31160668 GOETEBORG, 413 90  Sweden

This company is no longer actively traded on any major stock exchange.

Business Summary
Medfield Diagnostics AB is a Sweden-based developer of medical instrumentation. The Company develops, markets and sells diagnostic instrumentation based on microwave technology. The Company's microwave technology complements other imaging principles in two main ways. Firstly microwaves sense dielectric properties and provide high contrast for biological matter with different water content, thus enabling diagnosis of for example blood in brain tissue or tumors in breast tissue. Secondly microwave instruments are compact and thus used earlier in the healthcare chain, in emergency rooms and in ambulances. The Company’s products include R10; the M100, available on stroke services for night-time surveillance of patients at increased risk of stroke, as well as D1000 that is a diagnostic instrument for use in emergency rooms and ambulances to diagnose the type of stroke, ischemic (blood clot) or hemorrhagic (bleeding).

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/202412/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Founder MikaelPersson 6/2/2023
Acting Chief Executive Officer, Director BjornLarsson 1/9/2024 1/9/2024
Co-Founder AndreasFhager
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 10 (As of 12/31/2023)
Outstanding Shares: 79,345,155 (As of 3/31/2024)
Stock Exchange: AKT


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024